Cargando…
Potential Value of Matrix Metalloproteinase-13 as a Biomarker for Osteoarthritis
Background: Emerging knowledge has highlighted the role of matrix metalloproteinase (MMP)-13 in osteoarthritis (OA); however, the suitability of MMP-13 as a biomarker for OA remains unclear. Therefore, this study aimed to assess the potential value of MMP-13 as a biomarker for OA. Methods: The study...
Autores principales: | Xin, Xing, Tan, Qizhao, Li, Fang, Chen, Zhongqiang, Zhang, Ke, Li, Feng, Yang, Bin, Xing, Zhili, Zhou, Fang, Tian, Yun, Lv, Yang, Zhu, Tengjiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589078/ https://www.ncbi.nlm.nih.gov/pubmed/34778362 http://dx.doi.org/10.3389/fsurg.2021.750047 |
Ejemplares similares
-
Serum periostin level is not sufficient to serve as a clinically applicable biomarker of osteoarthritis
por: Tan, Qizhao, et al.
Publicado: (2022) -
Hypoxia-induced Wnt/β-catenin signaling activation in subchondral bone osteoblasts leads to an osteoarthritis-like phenotype of chondrocytes in articular cartilage
por: Li, Fang, et al.
Publicado: (2023) -
Relationship Between Magnetic Resonance T2-Mapping and Matrix Metalloproteinase 1,3 in Knee Osteoarthritis
por: Shi, Lei, et al.
Publicado: (2020) -
Correction to: Relationship Between Magnetic Resonance T2-Mapping and Matrix Metalloproteinase 1,3 in Knee Osteoarthritis
por: Shi, Lei, et al.
Publicado: (2021) -
Prognostic value of tissue inhibitor of metalloproteinase-matrix metalloproteinase biomarkers at 30 days in patients with acute myocardial infarction without reperfusion therapy
por: Pang, Hui-Fang, et al.
Publicado: (2021)